Calidi Biotherapeutics, Inc. Share Price & Technical Analysis
CLDI · $0.18 (0.00%)
Healthcare / Biotechnology
$0.18
0.00%
Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast can…
Price chart
Seasonality
May has 1 positive and 3 negative years (last 5 years shown)
0% return in May, -12% avg return in past 3 year May month.
-101% return in 2026, -124% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -9% | -20% | -71% | 0% | 0% | – | – | – | – | – | – | – | -101% |
| 25 | -34% | 18% | -33% | -18% | -29% | -40% | 167% | -77% | -6% | 0% | 0% | -20% | -74% |
| 24 | -47% | -25% | -6% | -66% | -7% | 0% | -20% | -29% | -1% | 6% | 70% | -46% | -171% |
| 23 | 1% | 0% | 0% | 0% | 1% | 1% | 0% | -13% | -61% | -33% | 0% | -26% | -128% |
| 22 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -2% | 0% | 1% | 1% | 2% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Oversold
Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck cancer, and sarcoma; and CLD-401 for the treatment of metastatic solid tumors. It also offers oncolytic virus platforms, such as NeuroNova and SuperNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$2.84M
P/E ratio
—
52W high
$19.20
52W low
$0.16
Volume
45,11,771
Beta
1.38
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Calidi Biotherapeutics, Inc. share price today?
- Calidi Biotherapeutics, Inc. (CLDI) last traded around $0.18 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CLDI have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CLDI. Download the app for real-time alerts.
- How can I analyze Calidi Biotherapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.